Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

  • Name

    Agilent Technologies, Inc.

  • CEO

    Mr. Padraig McDonnell

  • Website

    www.agilent.com

  • Sector

    Life Sciences Tools and Services

  • Year Founded

    1999

Profile

  • Market Cap

    $39.45B

  • EV

    $40.79B

  • Shares Out

    287.33M

  • Revenue

    $6,497M

  • Employees

    17,400

Margins

  • Gross

    54.39%

  • EBITDA

    24.07%

  • Operating

    20.22%

  • Pre-Tax

    23.7%

  • Net

    21.75%

  • FCF

    21.81%

Returns (5Yr Avg)

  • ROA

    10.71%

  • ROTA

    24.94%

  • ROE

    20.99%

  • ROCE

    16.06%

  • ROIC

    15.32%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $147.51

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $1,779M

  • Net Debt

    $1,337M

  • Debt/Equity

    0.53

  • EBIT/Interest

    15.28

Growth (CAGR)

  • Rev 3Yr

    1.89%

  • Rev 5Yr

    5%

  • Rev 10Yr

    3.24%

  • Dil EPS 3Yr

    14.48%

  • Dil EPS 5Yr

    7.57%

  • Dil EPS 10Yr

    8.89%

  • Rev Fwd 2Yr

    -0.21%

  • EBITDA Fwd 2Yr

    2.75%

  • EPS Fwd 2Yr

    2.13%

  • EPS LT Growth Est

    6.11%

Dividends

  • Yield

  • Payout

    19.26%

  • DPS

    $0.93

  • DPS Growth 3Yr

    6.98%

  • DPS Growth 5Yr

    7.8%

  • DPS Growth 10Yr

    6.1%

  • DPS Growth Fwd 2Yr

    6.76%

NYSE:A